HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Martin S Tallman Selected Research

Martin S Tallman Research Topics

Disease

58Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
07/2015 - 03/2002
41Acute Promyelocytic Leukemia
11/2015 - 01/2002
31Leukemia
03/2015 - 04/2002
16Neoplasms (Cancer)
11/2015 - 09/2004
14Myelodysplastic Syndromes (Myelodysplastic Syndrome)
10/2014 - 10/2002
14Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
03/2014 - 08/2002
12B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
11/2015 - 10/2002
8Hairy Cell Leukemia
10/2015 - 04/2002
8BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
06/2009 - 10/2002
6Breast Neoplasms (Breast Cancer)
08/2011 - 07/2003
5Hematologic Neoplasms (Hematological Malignancy)
11/2015 - 01/2002
5Thrombocytopenia (Thrombopenia)
02/2009 - 06/2002
4Residual Neoplasm
07/2014 - 04/2003
4Philadelphia Chromosome
02/2014 - 10/2002
4Anemia
11/2012 - 11/2005
4Infection
05/2012 - 08/2002
4Drug Toxicity (Drug Safety)
06/2009 - 11/2005
3Hemorrhage
09/2013 - 03/2005
3Kidney Diseases (Kidney Disease)
11/2012 - 09/2004
3Leukocytosis (Pleocytosis)
12/2009 - 04/2005
2Graft vs Host Disease (Graft-Versus-Host Disease)
10/2015 - 07/2010
2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
10/2014 - 12/2013
2Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
04/2013 - 05/2007
2Disease Progression
03/2013 - 05/2012
2Thrombosis (Thrombus)
09/2012 - 06/2007
2Chromosome Aberrations (Chromosome Abnormalities)
09/2012 - 09/2012
2Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2012 - 04/2009
2Disseminated Intravascular Coagulation
03/2009 - 06/2007
2Neutropenia
06/2007 - 02/2007
2Pure Red-Cell Aplasia
11/2005 - 09/2004
2Myeloid Leukemia (Leukemia, Myelocytic)
09/2004 - 04/2004
1Aplastic Anemia (Anemia, Hypoplastic)
10/2015

Drug/Important Bio-Agent (IBA)

27Tretinoin (Retinoic Acid)FDA LinkGeneric
11/2015 - 10/2002
15arsenic trioxide (Trisenox)FDA Link
07/2014 - 01/2002
11Cytarabine (Cytosar-U)FDA LinkGeneric
07/2015 - 08/2002
10Phosphotransferases (Kinase)IBA
12/2013 - 08/2003
9gemtuzumab (gemtuzumab ozogamicin)FDA Link
06/2013 - 03/2002
8imatinib (Gleevec)FDA Link
02/2014 - 10/2002
6DNA (Deoxyribonucleic Acid)IBA
12/2014 - 10/2009
6ErythropoietinFDA Link
11/2012 - 10/2002
5Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2015 - 07/2003
5fludarabineIBA
11/2015 - 05/2004
5purineIBA
10/2015 - 10/2002
5Daunorubicin (Cerubidine)FDA LinkGeneric
07/2015 - 01/2003
5Aligeron (AS 2)IBA
11/2010 - 11/2006
4rituximab (Mabthera)FDA Link
02/2015 - 10/2002
4alemtuzumab (Campath)FDA Link
02/2015 - 10/2002
4Azacitidine (5 Azacytidine)FDA Link
10/2014 - 10/2009
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2011 - 01/2004
3Proteins (Proteins, Gene)IBA
07/2015 - 08/2003
3Asparaginase (Elspar)FDA Link
03/2014 - 01/2003
3CladribineFDA LinkGeneric
06/2011 - 05/2004
3Prednisone (Sone)FDA LinkGeneric
11/2010 - 01/2003
3Eukaryotic Initiation Factor-4EIBA
10/2010 - 02/2005
3ArsenicIBA
09/2010 - 07/2008
3Immunoconjugates (Immunoconjugate)IBA
10/2009 - 10/2002
3Granulocyte Colony-Stimulating Factor (G-CSF)IBA
09/2009 - 02/2007
3Sirolimus (Rapamycin)FDA Link
01/2008 - 10/2005
3Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
02/2007 - 01/2004
3Monoclonal AntibodiesIBA
10/2006 - 10/2002
2fms-Like Tyrosine Kinase 3IBA
12/2014 - 01/2013
2Histones (Histone)IBA
10/2014 - 08/2006
2N- (2- aminophenyl)- 4- (N- (pyridin- 3- ylmethoxycarbonyl)aminomethyl)benzamide (MS 275)IBA
04/2014 - 10/2009
2Farnesyltranstransferase (Farnesyltransferase)IBA
03/2014 - 10/2002
2alpha-hydroxyglutarateIBA
06/2013 - 12/2010
2tebufenozide (Mimic)IBA
01/2013 - 06/2002
2HematinicsIBA
11/2012 - 02/2008
2Erythropoietin Receptors (Erythropoietin Receptor)IBA
11/2012 - 02/2008
2Mitoxantrone (Novantrone)FDA LinkGeneric
04/2012 - 03/2004
2Etoposide (VP 16)FDA LinkGeneric
04/2012 - 03/2004
2CaspasesIBA
10/2011 - 10/2009
2AEG 35156IBA
10/2011 - 10/2009
2X-Linked Inhibitor of Apoptosis ProteinIBA
10/2011 - 10/2009
2Protein Kinases (Protein Kinase)IBA
10/2010 - 10/2005
2Estrogens (Estrogen)FDA Link
01/2010 - 05/2009
2Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
10/2009 - 08/2002
2ExotoxinsIBA
10/2009 - 10/2002
2retinoic acid receptor alphaIBA
07/2008 - 04/2003
2AnthracyclinesIBA
01/2008 - 08/2002
2AntibodiesIBA
11/2005 - 01/2005
270-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA
10/2005 - 02/2005
2Interferon-alpha (Interferon Alfa)FDA Link
10/2005 - 05/2005
2valspodar (PSC 833)IBA
08/2004 - 03/2004
2InterferonsIBA
06/2003 - 04/2002
1Protein Isoforms (Isoforms)IBA
11/2015
1RNA (Ribonucleic Acid)IBA
11/2015
1Methotrexate (Mexate)FDA LinkGeneric
10/2015
1Cyclosporine (Ciclosporin)FDA LinkGeneric
10/2015
1Tacrolimus (Prograf)FDA LinkGeneric
10/2015
1Inhibitor of Apoptosis ProteinsIBA
07/2015
1malic acid (malate)IBA
04/2015

Therapy/Procedure

47Drug Therapy (Chemotherapy)
11/2015 - 06/2002
10Hematopoietic Stem Cell Transplantation
07/2013 - 07/2003
9Transplants (Transplant)
10/2015 - 02/2006
7Transplantation (Transplant Recipients)
10/2015 - 07/2003
6Cell Transplantation
10/2015 - 02/2008
5Homologous Transplantation (Allograft)
10/2015 - 02/2008
3Autologous Transplantation
05/2011 - 02/2008
3Adjuvant Chemotherapy
01/2010 - 07/2003
1Aftercare (After-Treatment)
10/2015